Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to Fenghuang Zhan

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Zhan, Fenghuang

Item TypeName
Academic Article Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
Academic Article Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
Academic Article Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.
Academic Article Tumor cell gene expression changes following short-term in vivo exposure to single agent chemotherapeutics are related to survival in multiple myeloma.
Academic Article NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.
Academic Article RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.
Concept Drug Resistance, Neoplasm
Academic Article Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeutics.
Academic Article Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
Academic Article Inhibition of Nek2 by small molecules affects proteasome activity.
Academic Article Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.
Academic Article Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
Academic Article Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus.
Academic Article NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.
Academic Article NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
Academic Article Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
Academic Article TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
Academic Article Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.
Academic Article Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma.
Academic Article Overexpression of RPS27a contributes to enhanced chemoresistance of CML cells to imatinib by the transactivated STAT3.
Academic Article Bortezomib resistance can be reversed by induced expression of plasma cell maturation markers in a mouse in vitro model of multiple myeloma.
Academic Article Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.
Academic Article NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma.
Academic Article Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a.
Academic Article RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma.
Academic Article Role of NEK2A in human cancer and its therapeutic potentials.

Search Criteria
  • Drug Resistance Neoplasm